One year of duodenal-jejunal bypass liner therapy (Endobarrier®) leads to perturbations in the metabolic profile of urine, plasma and stool of obese diabetic patients.
Proceedings article published in 2020 by
Aruchuna Ruban,
Zhigang Liu,
Michael Glaysher,
Hutan Ashrafian,
Alexander D. Miras,
Christina Prechtl,
Anthony Goldstone 
,
Madhawi Aldhwayan,
Navpreet Chhina,
Werd Al-Najim,
Nicholas Johnson,
Mayank Patel,
Jia Li,
James Byrne,
Julian Teare
,
Madhawi Aldhwayan,
Navpreet Chhina,
Werd Al-Najim,
Nicholas Johnson,
Mayank Patel,
Jia Li,
James Byrne,
Julian Teare
